Form 4 for RMD ResMed|
Accepted 2024-05-10 00:00:00 ET · period of report 2024-05-08 · accession 0001127602-24-014978 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-10 | 2024-05-08 | RMD | Sandercock Brett | CFO | M - OptEx | $101.64 | +12.0K | 105.1K | +13% | +$1.22M |
| D | 2024-05-10 | 2024-05-08 | RMD | Sandercock Brett | CFO | S - Sale+OE | $211.37 | -13.0K | 92.1K | -12% | -$2.75M |
| D | 2024-05-10 | 2024-05-08 | RMD | Sandercock Brett | CFO | M - OptEx | $0.00 | -12.0K | 10.9K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-05-08 | M | A | 12,000 | $101.64 | 105,056 | D | — | — | (F2) Includes 94.177 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan. |
| 2 | Common | ResMed Common Stock | 2024-05-08 | S | D | 13,000 | $211.37 | 92,056 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2024-05-08 | M | D | 12,000 | $0.00 | 10,883 | D | $101.64 · 2019-11-11 to 2025-11-14 | 12,000 ResMed Common Stock | (F3) Represents date options first became exercisable. Options vest 1/3 per year. |